Literature DB >> 11175040

Echocardiographic and Clinical Predictors of Mortality in Chronic Chagas' Disease.

Luis A. Rodriguez-Salas1, Eduardo Klein, Harry Acquatella, Franco Catalioti, Jose Ramon Gomez-Mancebo, Hector Gonzalez, Fernando Bosch, Juan Jose Puigbo.   

Abstract

BACKGROUND: In a prospective epidemiological study of chronic Chagas' disease, several clinical and echocardiographic variables were analyzed as predictors of mortality.
METHODS: Among 960 subjects seropositive for Chagas' disease who were examined between June 1981 and June 1992, 283 had echocardiograms.
RESULTS: During a mean follow-up period of 48.3 +/- 36.4 months (range, 1-156 months), 108 subjects died. Echocardiographic end-diastolic and -systolic left ventricular internal dimensions, fractional shortening, radius-to-thickness ratio, left ventricular mass, mitral E-point septal separation, and 17 other nonechocardiographic variables were predictors of death on univariate analysis (P < 0.001 for each). On stepwise multiple regression analysis of 215 subjects, significant risk covariates in a Cox model analysis were clinical group (P < 0.0001), M-mode echocardiographic E-point septal separation of 22 mm (P = 0.003), presence of first- or second-degree heart block (P = 0.003), chest radiologic cardiothoracic ratio >/= 0.55 (P = 0.012), presence of electrocardiographic ST segment elevation on precordial leads (P = 0.014), age >/= 56 years (P = 0.028), and presence of right bundle-branch block (P = 0.045). Patients with an apical aneurysm on two-dimensional echocardiography had an increased mortality (Chi-square = 11.5, P < 0.001).
CONCLUSIONS: Echocardiography is a valuable tool to assess the risk of death in prospective studies on chronic Chagas' heart disease.

Entities:  

Year:  1998        PMID: 11175040     DOI: 10.1111/j.1540-8175.1998.tb00607.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  15 in total

Review 1.  Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.

Authors:  Kevin M Bonney; David M Engman
Journal:  Am J Pathol       Date:  2015-04-07       Impact factor: 4.307

2.  Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Authors:  Kevin M Bonney; Joann M Taylor; Edward B Thorp; Conrad L Epting; David M Engman
Journal:  Parasitol Res       Date:  2015-01-11       Impact factor: 2.289

Review 3.  Chagas heart disease pathogenesis: one mechanism or many?

Authors:  Kevin M Bonney; David M Engman
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

4.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

5.  Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease.

Authors:  Edecio Cunha-Neto; Christophe Chevillard; Maryem Ouarhache; Sandrine Marquet; Amanda Farage Frade; Ariela Mota Ferreira; Barbara Ianni; Rafael Ribeiro Almeida; Joao Paulo Silva Nunes; Ludmila Rodrigues Pinto Ferreira; Vagner Oliveira-Carvalho Rigaud; Darlan Cândido; Charles Mady; Ricardo Costa Fernandes Zaniratto; Paula Buck; Magali Torres; Frederic Gallardo; Pauline Andrieux; Sergio Bydlowsky; Debora Levy; Laurent Abel; Clareci Silva Cardoso; Omar Ribeiro Santos-Junior; Lea Campos Oliveira; Claudia Di Lorenzo Oliveira; Maria Do Carmo Nunes; Aurelie Cobat; Jorge Kalil; Antonio Luiz Ribeiro; Ester Cerdeira Sabino
Journal:  J Clin Immunol       Date:  2021-03-03       Impact factor: 8.542

6.  Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go?

Authors:  Linda A Jelicks; Wade Koba; Herbert B Tanowitz; Rosalia Mendez-Otero; Antonio C Campos de Carvalho; David C Spray
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

7.  Predictive factors for the progression of chronic Chagas cardiomyopathy in patients without left ventricular dysfunction.

Authors:  Silvana de Araújo Silva; Eliane Dias Gontijo; João Carlos Pinto Dias; Camila Gomes de Souza Andrade; Carlos Faria Santos Amaral
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

8.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

9.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

10.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.